Matthew J. Brady to Phosphatidylinositol 3-Kinase
This is a "connection" page, showing publications Matthew J. Brady has written about Phosphatidylinositol 3-Kinase.
Connection Strength
0.102
-
The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta. 2012 Jun; 1822(6):952-60.
Score: 0.102